These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9199074

  • 1. [Comparison between low-molecular and unfractionated heparin in the prevention of thrombosis in patients with total endoprosthetic replacement of hip and knee joint].
    Rader CP, Kramer C, König A, Gohlke F, Eulert J.
    Z Orthop Ihre Grenzgeb; 1997; 135(1):52-7. PubMed ID: 9199074
    [Abstract] [Full Text] [Related]

  • 2. Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty.
    Rader CP, Kramer C, König A, Hendrich C, Eulert J.
    J Arthroplasty; 1998 Feb; 13(2):180-5. PubMed ID: 9526211
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.
    Colwell CW, Spiro TE.
    Clin Orthop Relat Res; 1995 Oct; (319):215-22. PubMed ID: 7554633
    [Abstract] [Full Text] [Related]

  • 4. [Experiences with an ankle joint motion device in prevention of thrombosis in patients after total endoprosthesis knee replacement].
    Rader CP, Kramer C, Hendrich C, König A, Gohlke F, Eulert J.
    Z Orthop Ihre Grenzgeb; 1998 Oct; 136(5):467-70. PubMed ID: 9823645
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
    Colwell CW, Spiro TE, Trowbridge AA, Stephens JW, Gardiner GA, Ritter MA.
    Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668
    [Abstract] [Full Text] [Related]

  • 6. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V, Vuorinen J, Myllynen P, Kivioja A, Lindevall K.
    Ann Chir Gynaecol; 1996 Dec; 85(4):359-63. PubMed ID: 9014067
    [Abstract] [Full Text] [Related]

  • 7. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD, Raskob GE, Pineo GF, Feldstein W, Rosenbloom D, Gafni A, Green D, Feinglass J, Trowbridge AA, Elliott CG.
    Arch Intern Med; 1997 Feb 10; 157(3):298-303. PubMed ID: 9040296
    [Abstract] [Full Text] [Related]

  • 8. Postoperative anticoagulation in vascular surgery: part 1. A retrospective comparison of clinical outcomes for unfractionated heparin versus low-molecular-weight heparin.
    Gramse CA, Hingorani A, Ascher E.
    J Vasc Nurs; 2001 Jun 10; 19(2):42-9; quiz 50-1. PubMed ID: 11395717
    [Abstract] [Full Text] [Related]

  • 9. Preventing DVT following total knee replacement: a review of recent clinical trials.
    Fitzgerald RH.
    Orthopedics; 1995 Jul 10; 18 Suppl():10-1. PubMed ID: 7479418
    [Abstract] [Full Text] [Related]

  • 10. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P, De Groote K, Annemans L.
    Arch Orthop Trauma Surg; 2004 Oct 10; 124(8):507-17. PubMed ID: 15365714
    [Abstract] [Full Text] [Related]

  • 11. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, Candardjis G.
    N Engl J Med; 1983 Oct 20; 309(16):954-8. PubMed ID: 6621623
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
    Ganzer D, Gutezeit A, Mayer G, Greinacher A, Eichler P.
    Z Orthop Ihre Grenzgeb; 1997 Oct 20; 135(6):543-9. PubMed ID: 9499523
    [Abstract] [Full Text] [Related]

  • 13. Enoxaparin in the prevention of deep venous thrombosis.
    Ament PW, Bertolino JG.
    Am Fam Physician; 1994 Dec 20; 50(8):1763-8. PubMed ID: 7977005
    [Abstract] [Full Text] [Related]

  • 14. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Dec 20; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 15. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J, ECHOS Trial Group.
    Int Angiol; 2006 Dec 20; 25(4):335-42. PubMed ID: 17164738
    [Abstract] [Full Text] [Related]

  • 16. [Potentials risks in drug prevention of thrombosis--low-molecular-weight heparin versus standard heparin].
    Ganzer D, Gutezeit A, Mayer G.
    Z Orthop Ihre Grenzgeb; 1999 Dec 20; 137(5):457-61. PubMed ID: 10549126
    [Abstract] [Full Text] [Related]

  • 17. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
    Chen JL, Chen J, Qiao SB, Guo YL, Wu YJ, Dai J, Yuan JQ, Qin XW, Yang YJ, Gao RL.
    Chin Med J (Engl); 2006 Mar 05; 119(5):355-9. PubMed ID: 16542576
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
    Marx A, Huhle G, Hoffmann U, Wang LC, Schüle B, Jani L, Harenberg J.
    Z Orthop Ihre Grenzgeb; 1999 Mar 05; 137(6):536-9. PubMed ID: 10666863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.